Work

A Phase 1b Study of Birinapant in Combination with 5-Azacitadine in Patients with Myelodysplastic Syndrome Who Are Naïve, Refractory or Have Relapsed to 5-Azacitadine

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.93.93

Authors: Gautam Borthakur, James M. Foran, Eunice S. Wang, Amol Rakkar, Hans Minderman, Jennifer Burns, Michael Andreeff, Raoul Tibes

Institutions: The University of Texas MD Anderson Cancer Center, Mayo Clinic, Mayo Clinic in Florida, Roswell Park Comprehensive Cancer Center, TetraLogic Pharmaceuticals (United States), Mayo Clinic in Arizona, Mayo Clinic Hospital, Mayo Clinic Comprehensive Cancer Center (Arizona)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2490583419

FWCI:

Cites:

Cited by: 4

Related to: 10